[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.825, "open": 0.81, "dayLow": 0.793, "dayHigh": 0.822, "regularMarketPreviousClose": 0.825, "regularMarketOpen": 0.81, "regularMarketDayLow": 0.793, "regularMarketDayHigh": 0.822, "payoutRatio": 0.0, "beta": 0.944, "forwardPE": -0.49670732, "volume": 336411, "regularMarketVolume": 336411, "averageVolume": 2688855, "averageVolume10days": 954960, "averageDailyVolume10Day": 954960, "bid": 0.7764, "ask": 0.8618, "bidSize": 2, "askSize": 2, "marketCap": 13212242, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 6.89, "priceToSalesTrailing12Months": 35.232647, "fiftyDayAverage": 0.8368, "twoHundredDayAverage": 2.4151, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 11966863, "profitMargins": 0.0, "floatShares": 15831583, "sharesOutstanding": 16219300, "sharesShort": 827960, "sharesShortPriorMonth": 656763, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.051, "heldPercentInsiders": 0.043070003, "heldPercentInstitutions": 0.15777999, "shortRatio": 1.75, "shortPercentOfFloat": 0.0511, "impliedSharesOutstanding": 16608900, "bookValue": 1.131, "priceToBook": 0.7202475, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -16460000, "trailingEps": -0.04, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 31.912, "enterpriseToEbitda": -0.747, "52WeekChange": -0.6447369, "SandP52WeekChange": 0.1116153, "quoteType": "EQUITY", "currentPrice": 0.8146, "targetHighPrice": 6.0, "targetLowPrice": 3.6, "targetMeanPrice": 4.86667, "targetMedianPrice": 5.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 4959000, "totalCashPerShare": 0.3, "ebitda": -16021000, "totalDebt": 4320000, "quickRatio": 0.919, "currentRatio": 1.123, "totalRevenue": 375000, "debtToEquity": 37.958, "revenuePerShare": 0.041, "returnOnAssets": -0.30345, "returnOnEquity": -0.90829, "grossProfits": 375000, "freeCashflow": 17670376, "operatingCashflow": -15543000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -44.834667, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -1.7922882, "postMarketPrice": 0.8, "postMarketChange": -0.014599979, "regularMarketChange": -0.0104, "regularMarketDayRange": "0.793 - 0.822", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2688855, "fiftyTwoWeekLowChange": 0.1746, "fiftyTwoWeekLowChangePercent": 0.27281252, "fiftyTwoWeekRange": "0.64 - 6.89", "fiftyTwoWeekHighChange": -6.0754, "fiftyTwoWeekHighChangePercent": -0.8817707, "fiftyTwoWeekChangePercent": -64.47369, "dividendDate": 1528675200, "earningsTimestamp": 1746187200, "earningsTimestampStart": 1758193140, "earningsTimestampEnd": 1758542400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.04, "epsForward": -1.64, "epsCurrentYear": -1.77, "priceEpsCurrentYear": -0.460226, "fiftyDayAverageChange": -0.022199988, "fiftyDayAverageChangePercent": -0.026529623, "twoHundredDayAverageChange": -1.6005001, "twoHundredDayAverageChangePercent": -0.6627055, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "corporateActions": [], "postMarketTime": 1752278263, "regularMarketTime": 1752264001, "exchange": "NCM", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.26061, "regularMarketPrice": 0.8146, "marketState": "CLOSED", "shortName": "iBio, Inc.", "longName": "iBio, Inc.", "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]